Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof
    21.
    发明授权
    Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof 失效
    针对TGF-β2型受体的人单克隆抗体及其医药用途

    公开(公告)号:US07579186B1

    公开(公告)日:2009-08-25

    申请号:US10130034

    申请日:2000-11-17

    IPC分类号: C12N5/06 C07K16/28

    摘要: Various human monoclonal antibodies that bind to human TGF-β type II receptor to inhibit the signal transduction of human TGF-β signal into cells are produced by immunizing human antibody-producing transgenic mice generated by genetic engineering techniques with the soluble human TGF-β type II receptor. Further, these human monoclonal antibodies were demonstrated to be effective for preventing and treating various diseases induced by human TGF-β in various organs (for example, tissue fibrosis).

    摘要翻译: 通过用可溶性人TGF-β型的遗传工程技术免疫产生的产生抗体的转基因小鼠,产生与人TGF-β2型受体结合以抑制人TGF-β信号向细胞中信号转导的各种人单克隆抗体 II受体。 此外,这些人单克隆抗体被证明对于预防和治疗各种器官(例如组织纤维化)中由人TGF-β诱导的各种疾病是有效的。